1. Home
  2. PCRX vs PBT Comparison

PCRX vs PBT Comparison

Compare PCRX & PBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • PBT
  • Stock Information
  • Founded
  • PCRX 2006
  • PBT 1980
  • Country
  • PCRX United States
  • PBT United States
  • Employees
  • PCRX N/A
  • PBT N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • PBT Oil & Gas Production
  • Sector
  • PCRX Health Care
  • PBT Energy
  • Exchange
  • PCRX Nasdaq
  • PBT Nasdaq
  • Market Cap
  • PCRX 604.7M
  • PBT 558.4M
  • IPO Year
  • PCRX 2011
  • PBT N/A
  • Fundamental
  • Price
  • PCRX $22.81
  • PBT $11.96
  • Analyst Decision
  • PCRX Buy
  • PBT
  • Analyst Count
  • PCRX 10
  • PBT 0
  • Target Price
  • PCRX $27.60
  • PBT N/A
  • AVG Volume (30 Days)
  • PCRX 787.3K
  • PBT 194.3K
  • Earning Date
  • PCRX 02-27-2025
  • PBT 01-01-0001
  • Dividend Yield
  • PCRX N/A
  • PBT 4.54%
  • EPS Growth
  • PCRX N/A
  • PBT 25.21
  • EPS
  • PCRX N/A
  • PBT 0.78
  • Revenue
  • PCRX $694,957,000.00
  • PBT $37,735,284.00
  • Revenue This Year
  • PCRX $4.83
  • PBT N/A
  • Revenue Next Year
  • PCRX $2.16
  • PBT N/A
  • P/E Ratio
  • PCRX N/A
  • PBT $15.12
  • Revenue Growth
  • PCRX 4.40
  • PBT 25.46
  • 52 Week Low
  • PCRX $11.16
  • PBT $10.14
  • 52 Week High
  • PCRX $34.01
  • PBT $15.79
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 71.48
  • PBT 52.54
  • Support Level
  • PCRX $18.18
  • PBT $11.51
  • Resistance Level
  • PCRX $22.88
  • PBT $12.14
  • Average True Range (ATR)
  • PCRX 1.14
  • PBT 0.45
  • MACD
  • PCRX 0.32
  • PBT 0.09
  • Stochastic Oscillator
  • PCRX 96.36
  • PBT 79.28

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About PBT Permian Basin Royalty Trust

Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.

Share on Social Networks: